Showing results (111-120 of 1,271) with videos related to
Sort By:
Pageof 128
Psychopharmacology Bulletin|July 25, 2009
Revisiting the effectiveness of standard antidepressants in bipolar disorder: are monoamine oxidase inhibitors superior?Alan G Mallinger, Ellen Frank, Michael E Thase, et al.Psychopharmacology Bulletin|January 1, 1990
Atypical neuroleptics in acute schizophrenia: a double-blind comparative study of remoxipride and haloperidolJ A den Boer, H G WestenbergPsychopharmacology Bulletin|September 16, 2009
Assessing rates and predictors of tachyphylaxis during the prevention of recurrent episodes of depression with venlafaxine ER for two years (PREVENT) studyAnthony J Rothschild, Boadie W Dunlop, David L Dunner, et al.Psychopharmacology Bulletin|September 16, 2009
Efficacy of omega-3 fatty acids in mood disorders - a systematic review and metaanalysisNina V Kraguljac, Victor M Montori, Mani Pavuluri, et al.Psychopharmacology Bulletin|September 16, 2009
A systematic review of augmentation strategies for patients with major depressive disorderRachael Fleurence, Rebecca Williamson, Yonghua Jing, et al.Psychopharmacology Bulletin|January 1, 1990
Ipsapirone: evidence for efficacy in depressionA H Heller, M Beneke, B Kuemmel, et al.Psychopharmacology Bulletin|January 1, 1990
Treatment of neuroleptic induced akathisia with the 5-HT2 antagonist ritanserinC H Miller, W W Fleischhacker, H Ehrmann, et al.Psychopharmacology Bulletin|October 21, 2003
Treatment of posttraumatic stress disorder: the impact of paroxetineJonathan R T DavidsonPsychopharmacology Bulletin|October 21, 2003
Obsessive-compulsive disorder: implications of the efficacy of an SSRI, paroxetinePhilip T NinanPsychopharmacology Bulletin|October 21, 2003
Advances in recognition and treatment of social anxiety disorder: a 10-year retrospectiveMurray B SteinPageof 128